Home > Global Health Center > Cardiovascular Disease Committee
Cardiovascular Disease Committee
We are committed to reducing the burden of cardiovascular disease through education, advocacy, and collaborative research.
What we want to achieve
Our Cardiovascular Disease Committee aims to significantly reduce the global impact of heart disease through strategic initiatives that span prevention, treatment, and policy reform. We seek to eliminate health disparities in cardiovascular outcomes by promoting equitable access to evidence-based care and resources. Through collaborative partnerships with healthcare providers, researchers, and policymakers, we work to advance innovative therapies, strengthen prevention programs, and establish comprehensive guidelines that improve patient outcomes. Our ultimate goal is to create a world where cardiovascular disease is preventable, treatable, and no longer a leading cause of mortality and morbidity.
Focus areas
Hypertension
Heart failure
Stroke
Arrhythmias
Cardiac devices
Committee members
Nilima Kundnani
Victor Babeș University of Medicine and Pharmacy Timișoara
Sameer Jamal
Hackensack Meridian School of Medicine
Latest publications
Theme Issue
Advances in Cardiac Electrophysiology and Device Innovation
The field of cardiac electrophysiology continues to evolve rapidly, driven by technological breakthroughs and innovative therapeutic approaches. This theme issue presents cutting-edge developments spanning from novel pacing strategies to artificial intelligence applications in device programming.
Review Article
The Stanford Legacy and the Future of Electrocardiographic Screening of Athletes
The purpose of this paper is to provide brief historical perspective, the experiences at our institution and our view of the future application of computerized Electrocardiography in screening for cardiovascular risk.
By Victor Froelicher et al. - Stanford University School of Medicine
Research Article
Cardiovascular Outcome in Type 2 Diabetes and Atrial Fibrillation - How to modify the increased cardiovascular risk?
The increased cardiovascular risk in patients with type 2 diabetes mellitus is further augmented by the presence of atrial fibrillation.
By Thomas Meinertz et al. - German Heart Foundation
Theme issues
Upcoming
Innovations in Arrhythmias
Challenges and Opportunities in Heart Failure
Advancements in Hypertension
Published
Researching cardiovascular disease?
We would like to hear from you. Write to us at [email protected]